肺功能检查不能预测连续流左心室辅助装置植入患者的死亡率
本研究纳入2005年7月至2015年9月间接受连续流左心室辅助装置植入的患者,其中263例术前完成一秒用力呼气容积检测,239例完成肺一氧化碳弥散量检测。Kaplan-Meier分析和多变量Cox回归显示,这两项肺功能指标与生存无关,1年和3年死亡率组间无差异,但指标值较高与住院时间缩短相关。结论提示单纯的肺功能异常不应排除机械循环支持候选资格。
要点
- 一秒用力呼气容积和肺一氧化碳弥散量均与连续流左心室辅助装置植入后的手术或长期死亡率无关。
- 两项指标值较高与住院时间缩短相关,仅肺一氧化碳弥散量与重症监护室住院时间延长相关。
- 单纯肺功能检查异常不应作为排除机械循环支持候选资格的依据。
核心结论
- 一秒用力呼气容积和肺一氧化碳弥散量不是连续流左心室辅助装置植入患者手术或长期死亡的预测因素。
研究设计与样本
- 单中心回顾性队列研究,2005年7月至2015年9月间接受连续流左心室辅助装置植入术的患者。
- 263例术前完成一秒用力呼气容积检测,239例完成肺一氧化碳弥散量检测。
- 采用Kaplan-Meier分析和多变量Cox回归评估死亡率,负二项回归评估术后重症监护室和住院时间。
主要发现
- 一秒用力呼气容积和肺一氧化碳弥散量与生存均无关联,组间1年和3年死亡率无差异(log rank P = .841和.713)。
- 两项指标值较高均与住院时间缩短相关;组分析中仅肺一氧化碳弥散量与重症监护室住院时间延长相关(P = .001)。
- 各组间呼吸机使用时间、术后肺炎、再插管和气管切开率相似。
临床怎么用
- 连续流左心室辅助装置植入前,不应仅因一秒用力呼气容积或肺一氧化碳弥散量异常而排除机械循环支持候选资格。
- 肺功能检查结果可用于辅助评估术后住院资源使用,但需结合其他临床因素综合判断。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To investigate the effect of pulmonary function testing on outcomes after continuous flow left ventricular assist device implantation. METHODS: A total of 263 and 239 patients, respectively, had tests of forced expiratory volume in 1 second and diffusing capacity of the lungs for carbon monoxide preoperatively for left ventricular assist device implantations between July 2005 and September 2015. Kaplan-Meier analysis and multivariable Cox regressions were performed to evaluate mortality. Patients were analyzed in a single cohort and across 5 groups. Postoperative intensive care unit and hospital lengths of stay were evaluated with negative binomial regressions. RESULTS: There is no association of forced expiratory volume in 1 second and diffusing capacity of the lungs for carbon monoxide with survival and no difference in mortality at 1 and 3 years between the groups (log rank P = .841 and .713, respectively). Greater values in either parameter were associated with decreased hospital lengths of stay. Only diffusing capacity of the lungs for carbon monoxide was associated with increased intensive care unit length of stay in the group analysis (P = .001). Ventilator times, postoperative pneumonia, reintubation, and tracheostomy rates were similar across the groups. CONCLUSIONS: Forced expiratory volume in 1 second and diffusing capacity of the lungs for carbon monoxide are not associated with operative or long-term mortality in patients undergoing continuous flow left ventricular assist device implantation. These findings suggest that these abnormal pulmonary function tests alone should not preclude mechanical circulatory support candidacy.
引用
- Bedzra EKS, Dardas TF, Cheng RK, et al. Pulmonary function tests do not predict mortality in patients undergoing continuous-flow left ventricular assist device implantation. J Thorac Cardiovasc Surg. 2017. PMID: 28526500. doi:10.1016/j.jtcvs.2017.02.069
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。